Abivax Sa revenue was $5.79M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $1.5M, up 198.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ABVX annual revenue was $5.4M, with -58.5% growth year-over-year.
ABVX past revenue growth
How has ABVX's revenue growth performed historically?
On Invalid Date, Abivax Sa (NASDAQ: ABVX) reported Q1 2026 revenue of $1.54 million up 42.98% year over year. In the same quarter last year, Abivax Sa's revenue was $1.08 million.
What was Abivax Sa's revenue in 2025?
Abivax Sa's annual revenue for the twelve months ending Dec 31, 2025 was $5.38 million, a 58.54% decrease year over year.
How much does Abivax Sa make in a day?
Based on Abivax Sa annual revenue for the past four years, ABVX makes an average of $19,420.65 per day.
What was Abivax Sa's annual revenue growth in the past year?
As of Q2 2026, Abivax Sa's revenue has grown -57.55% year over year. This is 299.75 percentage points lower than the US Biotechnology industry revenue growth rate of 242.2%. Abivax Sa's revenue in the past year totaled $5.79 million.
How much does Abivax Sa make in a year?
Abivax Sa's revenue by year for the past four years is:
Abivax Sa's revenue for the twelve months ending Dec 31, 2025 was $5.38 million, a 58.54% decrease year over year.
Abivax Sa's annual revenue for Dec 31, 2024 was $12.97 million, a 152.56% increase from 2023.
Abivax Sa's annual revenue for 2023 was $5.13 million, a 5.31% increase from 2022.
Abivax Sa's annual revenue for 2022 was $4.88 million, a 64.13% decrease from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.